Notably, we have discovered a significant association between TNFAIP3 and the key transcription factor RARγ, a finding that introduces a novel avenue for developing targeted therapeutic strategies in the clinical management of ESCC. The gene discussed is TNFAIP3; the disease is esophageal squamous cell carcinoma.